Comparison of FOLFIRINOX and Gemcitabine Plus Nab-paclitaxel for Treatment of Metastatic Pancreatic Cancer Using Korean Pancreatic Cancer (K-PaC) Registry

Lee, JC; Woo, SM; Shin, DW; Kim, J; Yang, SY; Kim, MJ; Kim, JW; Kim, JW; Lee, WJ; Cha, HS; Park, P; Kim, J; Hwang, JH

Hwang, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Bundang Hosp, 82,Gumi Ro 173 Beon Gil, Seongnam Si 13620, Gyeonggi Do Pro, Peoples R China.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020; 43 (9): 654

Abstract

Objective: By using the Korean Pancreatic Cancer (K-PaC) registry, we compared the clinical outcomes of FOLFIRINOX (FFX) and gemcitabine plus nab-pacl......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索